Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia
about
Glucose and Lipid Dysmetabolism in a Rat Model of Prediabetes Induced by a High-Sucrose Diet.Role of growth hormone-releasing hormone in dyslipidemia associated with experimental type 1 diabetesPlasma Periostin Levels Are Increased in Chinese Subjects with Obesity and Type 2 Diabetes and Are Positively Correlated with Glucose and Lipid ParametersClinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical ConsiderationsThe changes of subtypes in pediatric diabetes and their clinical and laboratory characteristics over the last 20 yearsTriglyceride glucose index, a marker of insulin resistance, is associated with coronary artery stenosis in asymptomatic subjects with type 2 diabetes.Analysis of risk factors and their interactions in type 2 diabetes mellitus: A cross-sectional survey in Guilin, China.Correlation between Glycated Hemoglobin and Triglyceride Level in Type 2 Diabetes Mellitus.A Synthetic-Biology-Inspired Therapeutic Strategy for Targeting and Treating Hepatogenous Diabetes.HDL cholesterol: reappraisal of its clinical relevance.4-Hydroxyisoleucine: A Potential New Treatment for Type 2 Diabetes Mellitus.Clinical benefits of pitavastatin: focus on patients with diabetes or at risk of developing diabetes.The PDK1 Inhibitor Dichloroacetate Controls Cholesterol Homeostasis Through the ERK5/MEF2 PathwayInfluence of IL13 on Periostin Secretion by Synoviocytes in Osteoarthritis.Independent relationship between serum ferritin levels and dyslipidemia in Chinese adults: A population study.DNA methylation markers associated with type 2 diabetes, fasting glucose and HbA1c levels: a systematic review and replication in a case-control sample of the Lifelines study.Susceptibility background for type 2 diabetes in eleven Mexican Indigenous populations: HNF4A gene analysis.Effect of Gum Arabic (Acacia Senegal) supplementation on visceral adiposity index (VAI) and blood pressure in patients with type 2 diabetes mellitus as indicators of cardiovascular disease (CVD): a randomized and placebo-controlled clinical trial.Lipid changes during basal insulin peglispro, insulin glargine, or NPH treatment in six IMAGINE trials.Liver-adipose tissue crosstalk: A key player in the pathogenesis of glucolipid metabolic disease.Metabolic profiling of follistatin overexpression: a novel therapeutic strategy for metabolic diseases.[Clinical importance of HDL cholesterol].[PCSK9 inhibitors in hypercholesterolemia. New hope for patients with diabetes mellitus?].Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy.Leaves Tea Improves Dyslipidemia in Diabetic Mice: A Lipidomics-Based Network Pharmacology StudyBody composition analysis, anthropometric indices and lipid profile markers as predictors for prediabetesDietary stearic acid regulates mitochondria in vivo in humans
P2860
Q33852238-781BE1FE-F9D0-4A4C-B609-80F55F3F2861Q36607551-AF45634E-63CA-413E-A824-AE463E6A4221Q36970152-7C0530D7-4018-4D6B-9449-01EA516DBEE6Q37011769-37A41EC7-3900-4BF6-8FDE-380EBC225CFCQ37124099-E923AB15-715B-4E54-BFA4-7BB3E557F33CQ37258174-17B92A47-BA3D-49C4-AC3D-57F166D47D49Q37677869-1915EE86-7783-4CED-B55D-D5D93642FB6BQ38676426-8DFC26F0-0BAA-4A65-A5BA-AAA87FDBC8FAQ38718299-C9B7A48B-AE58-47E4-8620-E00BDC87F5C0Q38739884-6DA5047B-F03A-4BFA-9B21-08444D2D94D5Q38827078-6090CD71-A2B4-4D3B-816C-AF956A951FC9Q38881481-AD9760B6-5060-49C6-AE15-0EC37AB6696EQ41632623-F92320FB-DB63-47B0-AE10-CCF30324E478Q42315900-0473E7F3-9022-4F3E-871B-EC67631E53B0Q47259072-56F33F8B-87A6-4191-A8AE-2CD5F177098DQ47430758-D436289B-321A-49C7-864D-D715C4783A55Q47791312-3EE035D8-17D9-4F26-A78A-D2F9B7C13059Q51244819-30A11D7A-17C4-46FB-A90F-5C36F3BB7DC1Q51597934-AEF6AF61-E45E-4851-9E7F-1DBB3CBA14E8Q52546360-4C524348-19EC-4ADD-AF3A-FFB8AC341E0AQ52606244-A62C7A2F-4B56-4D18-8D22-9A4BDC9577EFQ52813315-1971A46A-6543-408A-8198-5155EBDA2BF1Q53204305-2C9368A6-81F0-48ED-B61C-C96C34EE97D6Q55516148-B08DD720-CB15-44DE-BB34-97588821929BQ58698291-209F8F46-9070-424E-BD06-A32E98DA2999Q58775276-DCD2EC63-D00D-42F7-A9C4-C9AA858CFBBAQ58797795-573B17EF-8C1B-4FBF-8BEB-EDC111C64D22
P2860
Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia
@ast
Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia
@en
Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia
@nl
type
label
Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia
@ast
Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia
@en
Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia
@nl
prefLabel
Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia
@ast
Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia
@en
Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia
@nl
P2860
P3181
P1476
Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia
@en
P2093
Klaus G Parhofer
P2860
P304
P3181
P356
10.4093/DMJ.2015.39.5.353
P407
P577
2015-10-01T00:00:00Z